Status:
UNKNOWN
Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Acute Myocardial Infarction
Left Ventricular Thrombus
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
A multi-center study will be done to explore the optimal regimen of antithrombotic therapy for acute myocardial infarction with left ventricular mural thrombus. The investigators will evaluate the dif...
Eligibility Criteria
Inclusion
- acute myocardial infarction with left ventricular mural thrombus
Exclusion
- BARC bleedings ≥ 2
- atrial fibrillation
- acute stroke or other systemic circulation embolism
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03415386
Start Date
June 1 2020
End Date
June 1 2022
Last Update
February 11 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.